NGB Laboratories

Surat, India Founded: 2017 • Age: 9 yrs
NGB Laboratories develops and manufactures a range of pharmaceutical products, including antibiotics.
Annual revenue $1.4M Latest available
Total funding - Funding intelligence
Employees 3 Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 9 Brand Intelligence

About NGB Laboratories

NGB Laboratories is a company based in Surat (India) founded in 2017. It operates as a B2B. The company has 3 employees as of March 31, 2022. NGB Laboratories operates in a competitive market with competitors including Enzene Biosciences, Hybio Pharmaceutical, Suanfarma, Nephron Pharmaceuticals and AmbioPharm, among others.

  • Headquarter Surat, India
  • Employees 3 as on 31 Mar, 2022
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Legal Name Ngb Laboratories Private Limited
  • Date of Incorporation 17 Feb, 2014
  • Jurisdiction Surat, Gujarat, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
    $1.42 M (USD)
    144.05
    as on Mar 31, 2022
  • Net Profit
    -$1.95 M (USD)
    -60.94
    as on Mar 31, 2022
  • EBITDA
    -$1.79 M (USD)
    -142.25
    as on Mar 31, 2022
  • Latest Funding Round
  • Investors
  • Employee Count
    3

    as on Mar 31, 2022

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of NGB Laboratories

Investments & Acquisitions by NGB Laboratories

Investments

Financial Statements - NGB Laboratories

Ngb Laboratories Comparisons

+
Add Comparison
Available on Premium

Competitors of NGB Laboratories

NGB Laboratories operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Enzene Biosciences, Hybio Pharmaceutical, Suanfarma, Nephron Pharmaceuticals and AmbioPharm, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Company specializing in development of Biosimilars
domain founded_year HQ Location
Polypeptide drugs and APIs are developed and manufactured.
domain founded_year HQ Location
Generics, nutraceuticals, and APIs are developed by Suanfarma.
domain founded_year HQ Location
Sterile pharmaceutical products are manufactured and contract services are provided.
domain founded_year HQ Location
CDMO and analytical services for peptide development are provided.
domain founded_year HQ Location
APIs and finished dosage forms are developed and manufactured.

Latest news on Ngb Laboratories

Frequently Asked Questions about NGB Laboratories

NGB Laboratories was founded in 2017.

NGB Laboratories is headquartered in Surat, India. It is registered at Surat, Gujarat, India.

As of Mar 31, 2022, the latest employee count at NGB Laboratories is 3.

Annual revenue of NGB Laboratories is $1.42M as on Mar 31, 2022.

NGB Laboratories, based in Surat, focuses on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and antibiotics and medicines. NGB Laboratories develops and manufactures a range of pharmaceutical products, including antibiotics. The company prioritizes operational excellence, innovation, and customer-centric approaches for success.

NGB Laboratories's top competitors include Nephron Pharmaceuticals, Suanfarma and Enzene Biosciences.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available